Medical Journal Raises Questions about Lexapro
Observers of pharmaceudical safety, including the Food and Drug Administration (FDA) and, most recently, the medical journal Frontiers in Evolutionary Psychology, have raised important questions about the safety of antidepressants, known as selective serotonin reuptake inhibitors (SSRIs), such as Lexapro (escitalopram). For many patients and their doctors, the concern is that the potential risk of Lexapro to a developing fetus is more significant than the potential detriment to the child’s mother.
Has your child been born with an SSRI-related birth defect? Did you take Lexapro or another SSRI during your pregnancy? The two may be more closely related than you might first think. You need to know the latest in medical research and legal conclusions. To find out everything you should learn, contact the professionals and attorneys at Fears Nachawati today. For your free consultation, call us at 1.866.545.8364 or email email@example.com. We’re ready to fight for you!